ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $74,082 | -91.1% | 114,131 | -76.5% | 0.00% | -89.7% |
Q3 2022 | $835,000 | -28.1% | 485,434 | -48.2% | 0.03% | -17.1% |
Q2 2022 | $1,162,000 | +198.7% | 936,900 | +337.8% | 0.04% | +150.0% |
Q3 2021 | $389,000 | +221.5% | 214,000 | +367.2% | 0.01% | +366.7% |
Q2 2021 | $121,000 | +181.4% | 45,800 | +166.3% | 0.00% | -50.0% |
Q3 2020 | $43,000 | – | 17,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
G&S Capital LLC | 18,000 | $34,000 | 0.03% |